8 Immunotherapy/Antibody Therapeutics companies

We are a life science venture capital investor, delivering knowledge, network, and capital to companies.

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Accelerating life-extending therapies, treatments and cures for all myeloma patients.

Curie.Bio is a new model for venture capital in biotech. We are focused on a singular mission – helping founders launch therapeutics companies that go on to rai…

Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent i…

4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.

Equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.

Aditum Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.